Related Experiment Video

Updated: Apr 13, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Correction to Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity

Milan Bruncko, Le Wang, George S Sheppard

    Journal of Medicinal Chemistry
    |May 2, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
    14:34

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

    Published on: April 3, 2026

    179
    Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
    10:58

    Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

    Published on: July 25, 2013

    17.7K

    Related Experiment Videos

    Last Updated: Apr 13, 2026

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
    10:33

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

    Published on: October 26, 2015

    11.9K
    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
    14:34

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

    Published on: April 3, 2026

    179
    Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
    10:58

    Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

    Published on: July 25, 2013

    17.7K

    Related Concept Videos

    Structure-Activity Relationships and Drug Design01:28

    Structure-Activity Relationships and Drug Design

    2.2K
    Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
    SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
    2.2K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.2K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.2K

    Articles linked to this work by shared authors, journal, and citation graph.

    A Novel Assay Platform for Targeted Protein Degradation Monitoring: Case Study of Antibody Free Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) for MALT1 Target Quantification.

    The AAPS journal·2026

    Associations of Insomnia, Fatigue, and Overtime Work With Self-Reported Medication Errors Among Perianesthesia Nurses: A Cross-Sectional Study.

    International nursing review·2026

    Changes in perceived stress among family caregivers of people living with dementia: An exploratory longitudinal network analysis.

    Geriatric nursing (New York, N.Y.)·2026

    Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human Studies.

    Journal of medicinal chemistry·2026

    Dynamic Relationship Between Sleep Patterns and Behavioral and Psychological Symptoms of Dementia: Longitudinal Observational Study.

    JMIR aging·2026

    Investigating the Relationship between In Vitro and In Vivo Performance: The Role of Drug Loading, Release Rate, and Surface Area.

    Molecular pharmaceutics·2026

    Structural and Mechanistic Studies of ADEPs Yield Potent Antibacterials and a Drug Formulation Strategy for Tuberculosis.

    Journal of medicinal chemistry·2026

    A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma.

    Journal of medicinal chemistry·2026

    From Fragment Hit to Clinical Candidate: Discovery of Dual H1R/H4R Ligands with Superior Efficacy in Allergic Conjunctivitis.

    Journal of medicinal chemistry·2026

    Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria.

    Journal of medicinal chemistry·2026

    Discovery of a Covalent NLRP3 LRR-Domain Probe: Reversing Renal Fibrosis via Immunometabolic Reprogramming in Organoid and Murine Models.

    Journal of medicinal chemistry·2026

    Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.

    Journal of medicinal chemistry·2026

    Machine learning-driven discovery of TGFBR1 inhibitors from Mangifera indica for Atorvastatin-based antidiabetic therapy.

    3 Biotech·2026

    Sample-efficient generative molecular design using memory manipulation.

    Nature machine intelligence·2026

    Knowledge graph and machine learning-guided virtual screening prioritizes putative blockers of the PSMD11/Rpn6-EBOV glycoprotein interface.

    Frontiers in pharmacology·2026

    Molecular Entropies of Conformationally Flexible, Gas-Phase Forms of Clinical Drugs: A Black-Box Approach Versus Systematic Sampling.

    Journal of computational chemistry·2026

    Multitarget Drug Design for Cardiovascular Disease: Bridging Chemistry and Medicine.

    ChemMedChem·2026

    Dendrimer-Based Nano Artesunate/β-Glucan as a Promising Antimalarial Candidate: Insights from in Vivo Evaluations.

    Acta tropica·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us